 Component GO Term   cell    And related genes <body> Component GO Term cell  and related genes   Total 4087 
Page number 60 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64   |   65   |   66   |   67   |   68   |   69   |   70   |   71   |   72   |   73   |   74   |   75   |   76   |   77   |   78   |   79   |   80   |   81   |   82   |   83   |   84   |   85   |   86   |   87   |   88   |   89   |   90   |   91   |   92   |   93   |   94   |   95   |   96   |   97   |   98   |   99   |   100   |   101   |   102   |   103   |   104   |   105   |   106   |   107   |   108   |   109   |   110   |   111   |   112   |   113   |   114   |   115   |   116   |   117   |   118   |   119   |   120   |   121   |   122   |   123   |   124   |   125   |   126   |   127   |   128   |   129   |   130   |   131   |   132   |   133   |   134   |   135   |   136   |   137  
    Gene Name  ORF Name  Function GO Term  Process GO Term   Component GO Term   Interacting Genes  Description  Gene Product  Phenotype     PCL6   YER059W  cyclin-dependent protein kinase, intrinsic regulator activity  regulation of glycogen biosynthesis*   cyclin-dependent protein kinase holoenzyme complex   YBR141C	YER156C	YOR392W	YJL084C	YLR190W	YPL031C	YDL224C	YBR160W	  PHO85 cyclin    Null mutant is viable. A Ty insertion mutant exhibits slow growth.     PCL7   YIL050W  cyclin-dependent protein kinase, intrinsic regulator activity  regulation of glycogen biosynthesis*   cyclin-dependent protein kinase holoenzyme complex   YLR190W	YNL218W	YLR449W	YPL031C	YDL224C	YLR295C	YBR160W	  PHO85 cyclin  cyclin       PCL8   YPL219W  cyclin-dependent protein kinase, intrinsic regulator activity  regulation of glycogen biosynthesis*   cyclin-dependent protein kinase holoenzyme complex   YPL031C	YJR091C	  PHO85 cyclin  cyclin  Null mutant is viable.     PCL9   YDL179W  cyclin-dependent protein kinase, intrinsic regulator activity  cell cycle   cyclin-dependent protein kinase holoenzyme complex   YMR147W	YDR388W	YBL045C	YPL031C	  PHO85 cyclin    Null mutant is viable.     PCM1   YEL058W  phosphoacetylglucosamine mutase activity  N-acetylglucosamine biosynthesis   cytoplasm   YNL218W	  Phosphoacetylglucosamine Mutase  phosphoacetylglucosamine mutase  Null mutant is inviable; a Ty insertion mutant exhibits slow growth.     PCP1   YGR101W  peptidase activity  mitochondrion organization and biogenesis*   mitochondrion   YJL213W	YHL021C	  processing of cytochrome c peroxidase  rhomboid protease  Null: lack of Ccp1 maturation, slow growth on non-fermentable media     PCS60   YBR222C  AMP binding  biological_process unknown   cytoplasm*   YAR020C	  Probable AMP-binding protein         PCT1   YGR202C  choline-phosphate cytidylyltransferase activity  phosphatidylcholine biosynthesis*   nucleus*   YGL137W	  phosphorylcholine transferase; or cholinephosphate cytidylyltransferase  cholinephosphate cytidylyltransferase|phosphorylcholine transferase  Null mutant is viable     PDA1   YER178W  pyruvate dehydrogenase (lipoamide) activity  pyruvate metabolism   mitochondrion*   YGR229C	YKL124W	YBR221C	YMR308C	YDR430C	YJR091C	YGL137W	YJL128C	YLR418C	YNL192W	  alpha subunit of pyruvate dehydrogenase (E1 alpha)  pyruvate dehydrogenase alpha subunit (E1 alpha)  Null mutant is viable, exhibits reduced growth on glucose and increased formation of petites     PDB1   YBR221C  pyruvate dehydrogenase (lipoamide) activity  pyruvate metabolism   mitochondrion*   YLR345W	YFL018C	YPL259C	YBR208C	YFR004W	YDR069C	YER178W	YPL151C	YNL071W	YGR193C	YBR044C	YGL130W	YMR308C	YDR430C	YML059C	YER081W	YLR218C	YLR418C	YBR229C	  beta subunit of pyruvate dehydrogenase (E1 beta)  pyruvate dehydrogenase beta subunit (E1 beta)  Null mutant is viable     PDC2   YDR081C  transcription regulator activity  transcription from Pol II promoter*   nucleus     Regulates transcription of PDC1 and PDC5, which encode pyruvate decarboxylase  asparagine and serine-rich protein  Null mutant is viable but shows strongly reduced pyruvate decarboxylase specific activity; slow, res     PDI1   YCL043C  protein disulfide isomerase activity  protein folding   endoplasmic reticulum lumen   YER189W	YLR354C	YDR518W	YJR076C	YIR001C	YLR233C	YIL035C	YOL126C	  Catalyzes the formation and isomerization of disulfide bonds during the folding of secretory protein  protein disulfide isomerase  Null mutant is inviable     PDR1   YGL013C  DNA binding*  regulation of transcription from Pol II promoter*   nucleus   YDR412W	YGL013C	  general positive regulator of permeability genes  zinc finger transcription factor of the Zn(2)-Cys(6) binuclear cluster domain type  pleiotropic drug resistance, resistant to borrelidin, oligomycin, antimycin, cycloheximide, antibiot     PDR10   YOR328W  ATP-binding cassette (ABC) transporter activity  multidrug transport   plasma membrane     Putative ABC transporter highly similar to Pdr5p  ABC transporter (putative)|highly similar to Pdr5p       PDR11   YIL013C  ATP-binding cassette (ABC) transporter activity  sterol transport   membrane   YDR174W	  ATP-dependent permease, member of ATP-binding cassette (ABC) transporter family  ABC transporter (putative)       PDR12   YPL058C  xenobiotic-transporting ATPase activity*  transport*   plasma membrane     similar to Pdr5p  multidrug resistance transporter  Null mutant is viable, sensistive to weak organic acids.     PDR15   YDR406W  ATP-binding cassette (ABC) transporter activity  transport   integral to membrane     similar to Pdr5p and Pdr10p  multidrug resistance transporter (putative)       PDR16   YNL231C  phosphatidylinositol transporter activity  response to drug*   cytoplasm   YGL014W	YHR007C	YNL192W	  involved in pleiotropic drug resistance by controlling lipids in various cellular compartments; posi  Pdr17p homolog|Sec14p homolog  Null mutant is viable, exhibits hypersensitivity to azole inhibitors of ergosterol biosynthesis, alt     PDR17   YNL264C  phosphatidylinositol transporter activity  response to drug*   cytoplasm   YNL098C	YLR113W	YDR126W	  involved in pleiotropic drug resistance by controlling lipids in various cellular compartments; puta  Pdr16p homolog|Sec14p homolog  Null mutant is viable, exhibits no observable phenotypes; pdr16 pdr17 double deletion mutants exhibi     PDR18   YNR070W  ATP-binding cassette (ABC) transporter activity  transport   membrane     pleiotropic drug resistance  ABC transporter of the PDR family  Null: viable     PDR3   YBL005W  DNA binding*  regulation of transcription from Pol II promoter*   nucleus*   YLR100W	  Zinc-finger transcription factor related to Pdr1p    pleiotropic drug resistance     PDR5   YOR153W  xenobiotic-transporting ATPase activity  response to drug*   plasma membrane   YAL053W	YNL236W	  multidrug resistance transporter  multidrug resistance transporter  pleiotropic drug resistance     PDR8   YLR266C  DNA binding*  response to stress*   nucleus   YNL113W	  Pleiotropic Drug Resistance  zinc finger transcription factor  Null: Slight resistance to hygromycin B. Other phenotypes: Artificial activation and overexpression     PDS1   YDR113C  protein binding  protein-nucleus import*   nucleus*   YGR060W	YGR098C	YDL116W	  May be an anaphase inhibitor that plays a critical role in control of anaphase by both the anaphase  42 kDa nuclear securin  Null mutant is viable but is temperature-sensitive; shows higher rates of chromosome loss at permiss     PDS5   YMR076C  structural molecule activity  mitotic chromosome condensation*   condensed nuclear chromosome     Precocious Dissociation of Sister chromatids         PDX1   YGR193C  protein binding  acetyl-CoA biosynthesis from pyruvate   mitochondrion*   YNL121C	YBR221C	YDR430C	YBR114W	YMR106C	  Plays a structural role in pyruvate dehydrogenase complex  pyruvate dehydrogenase complex protein X component  Null mutant is viable     PEA2   YER149C  cytoskeletal regulatory protein binding  establishment of cell polarity (sensu Saccharomyces)*   actin cap (sensu Saccharomyces)*   YDL233W	YOR315W	YLL021W	YIL040W	YKL034W	YGL127C	YBR234C	YDL029W	YNL298W	YLR229C	YGR078C	YEL003W	YNL192W	YLR330W	  Pea2p is localized with Spa2p to sites of polarized growth and is required for efficient mating and  coiled-coil domain  Null mutant is viable, exhibits defects in mating that subtly affect mating efficiency; pea2 mutants     PEP1   YBL017C  signal sequence binding  protein-vacuolar targeting*   Golgi apparatus   YPL049C	YDR432W	YOR181W	  vacuolar protein sorting receptor for carboxypeptidase Y and proteinase A; related to Sortilin  Type I integral membrane protein 166aa cytoplasmic tail, 1300 aa lumenal domain  proteinase deficient     PEP12   YOR036W  t-SNARE activity  Golgi to vacuole transport   Golgi apparatus*   YBR288C	YGL095C	YDR100W	YMR197C	YBL102W	YAL032C	YBL050W	YGL161C	YLR447C	YPL151C	YFL038C	YER031C	YCL032W	  integral membrane protein; c-terminal TMD; located in endosome  c-terminal TMD|integral membrane protein  proteinase deficient     PEP3   YLR148W  protein binding  late endosome to vacuole transport*   vacuolar membrane (sensu Fungi)*   YDL006W	YAL002W	YDR170C	YMR231W	YPL045W	YLR396C	YDR080W	  vacuolar membrane protein  vacuolar membrane protein  Null mutant is viable, exhibits growth defects at 37 degrees celsius, exhibits vacuolar protein sort   </body> 